Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 52: 338, 2006; 10.1373/clinchem.2005.061911
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van Sickle, D.
Right arrow Articles by Chertow, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van Sickle, D.
Right arrow Articles by Chertow, D.
Related Collections
Right arrow Laboratory Management
Right arrow General Clinical Chemistry
Right arrow Drug Monitoring and Toxicology
(Clinical Chemistry. 2006;52:338.)
© 2006 American Association for Clinical Chemistry, Inc.


Letters to the Editor

Inappropriate Reference Intervals for Carboxyhemoglobin at Some Florida Hospitals

David Van Sickle1,2,a and Daniel Chertow1,3

1 Epidemic Intelligence Service, Centers for Disease Control, and Prevention, Atlanta, GA
2 Air Pollution and, Respiratory Health Branch, Centers for Disease Control, and Prevention, Atlanta, GA
3 Bureau of Epidemiology, Florida Department of Health, Tallahassee, FL

aAddress correspondence to this author at: Air Pollution and Respiratory Health Branch, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, MS E-17, Atlanta, GA 30333. E-mail dvansickle{at}cdc.gov.


To the Editor:

We recently conducted an investigation of unintentional carbon monoxide (CO) poisonings in hurricane-affected areas of Florida during the 2004 hurricane season (1). During this process, we reviewed the medical records of 167 persons treated for CO poisoning at 10 hospitals around the state, including 2 with hyperbaric oxygen chambers.

Blood carboxyhemoglobin (HbCO) concentrations are used to confirm the diagnosis of CO poisoning, although these concentrations are not always well correlated with clinical manifestation or outcome. However, a 1995 survey of 23 hospitals and laboratories in the Boston area that provide HbCO measurement found wide variation in the reference intervals among facilities; 38% used inappropriately high concentrations for nonsmokers (2).

In our investigation, we found that 2 of 10 (20%) hospitals used excessively high upper limits for the reference interval for blood HbCO concentrations. Although the majority of hospitals considered HbCO values <3% to be normal in nonsmokers, these 2 hospitals used <20% as the threshold for normal HbCO in nonsmokers. At these facilities, laboratory results with blood HbCO concentrations <20% were not indicated as increased, and the reference concentration printed beside the result noted <20% as normal. These hospitals have been contacted and are reviewing their reference intervals internally. Although all individuals included in our study had been (by definition) diagnosed with CO poisoning, a total of 27 patients at one hospital (or 50% of the total number of patients treated at that facility) and 4 patients at another (44% of the total number of patients treated at the second hospital) had increased blood HbCO concentrations (>3%) that were reported as normal in their laboratory results.

The use of appropriate reference intervals for blood HbCO is essential, given the nonspecific symptoms of CO poisoning and the potential for harm resulting from a missed diagnosis. Recognizing HbCO saturation between 3% and 20% as abnormal is particularly important for evaluating those individuals whose presentation to medical care may have been delayed, those who received supplemental oxygen before blood sampling, or those with occult sources of exposure. As Marshall et al. (2) suggested, inappropriate blood HbCO reference intervals may mislead physicians unfamiliar with background saturations, possibly causing "misdiagnoses, false reassurances, and perhaps less aggressive treatment than might be warranted."

Although no national standards for measuring blood HbCO exist, reference intervals (<2% to 3% in nonsmokers; <7% to 9% in current smokers) have been established from population-based surveys (3), cross-sectional epidemiologic studies (4)(5), and population exposure research (6). We encourage all hospitals and laboratories to review their blood HbCO reference intervals and update them as needed to ensure that concentrations currently recommended in the scientific literature are being used.


References

  1. . Centers for Disease Control and Prevention. Carbon monoxide poisoning from hurricane-associated use of portable generators—Florida, 2004. MMWR Morb Mortal Wkly Rep 2005;54:697-700.[Medline] [Order article via Infotrieve]
  2. Marshall MD, Kales SN, Christiani DC, Goldman RH. Are reference intervals for carboxyhemoglobin appropriate? A survey of Boston area laboratories. Clin Chem 1995;41:1434-1438.[Abstract/Free Full Text]
  3. Radford EP, Drizd TA. Blood carbon monoxide levels in persons 3–74 years of age: United States, 1976–80. Adv Data 1982;229:1187-1195.
  4. Stewart RD, Baretta ED, Platte LR, Stewart EB, Kalbfleisch JH, Van Yserloo B, et al. Carboxyhemoglobin levels in American blood donors. JAMA 1974;229:1187-1195.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  5. Stewart RD. The effect of carbon monoxide on humans. Annu Rev Pharmacol 1975;15:409-423.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  6. . United States Environmental Protection Agency. Air quality criteria for carbon monoxide. EPA-600/8-90-045A 1990 United States Environmental Protection Agency Washington, DC. .




This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van Sickle, D.
Right arrow Articles by Chertow, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van Sickle, D.
Right arrow Articles by Chertow, D.
Related Collections
Right arrow Laboratory Management
Right arrow General Clinical Chemistry
Right arrow Drug Monitoring and Toxicology


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS